Do Recent Advances in Diagnostic and Therapeutic Procedures Negate the Benefit of Postmastectomy Radiotherapy in N1 Patients With a Low Risk of Locoregional Recurrence?

Recent advances in breast cancer management might make the use of postmastectomy radiotherapy (PMRT) redundant in the treatment of pT1/T2N1 patients. We investigated the impact of PMRT on disease-free survival (DFS) in these patients who have a low risk of locoregional recurrence (LRR) after contemp...

Descripción completa

Detalles Bibliográficos
Autores principales: Chang, Jee Suk, Lee, Jeongshim, Kim, Kyung Hwan, Sohn, Joo Hyuk, Kim, Seung Il, Park, Byeong-Woo, Chung, Hyun Cheol, Keum, Ki Chang, Suh, Chang-Ok, Kim, Yong Bae
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2015
Materias:
5700
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4616432/
https://www.ncbi.nlm.nih.gov/pubmed/26287410
http://dx.doi.org/10.1097/MD.0000000000001259

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4616432/
https://www.ncbi.nlm.nih.gov/pubmed/26287410
http://dx.doi.org/10.1097/MD.0000000000001259

Ejemplares similares